Jasper Therapeutics
Quarterly Financials
| Values in thousands | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|
Revenue | $1,174 | $0 | $0 | $0 |
Gross Profit | 587 | -299 | -288 | |
EBITDA | 45,874 | -19,348 | -15,694 | -14,784 |
EBIT | 47,002 | -19,889 | -15,993 | -15,072 |
Net Income | 46,948 | -18,637 | -14,583 | -13,728 |
Net Change In Cash | 1,174 | 0 | 0 | 0 |
Free Cash Flow | -21,230 | -14,326 | -11,837 | -15,761 |
Cash | 71,637 | 92,502 | 106,819 | 118,475 |
Basic Shares | 14,584 | 15,000 | 14,986 | 13,334 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $13,511 | $6,196 |
Gross Profit | -1,108 | -1,310 | -566 | |
EBITDA | -76,239 | -64,985 | -38,210 | -31,166 |
EBIT | -66,093 | -39,520 | -31,732 | |
Net Income | -71,269 | -64,465 | -24,174 | -23,984 |
Net Change In Cash | 0 | 0 | 13,511 | 6,196 |
Cost of Revenue | -46,379 | 64,863 | ||
Free Cash Flow | -63,154 | -52,334 | -46,434 | -36,106 |
Cash | 71,637 | 86,887 | 38,250 | 84,701 |
Basic Shares | 14,584 | 10,439 | 3,648 | 1,139 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-12-31 | -$1.62 |
2024-09-30 | -$1.24 |
2024-06-30 | -$0.97 |
2024-03-31 | -$1.03 |
